These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35150042)

  • 1. CTLA-4 polymorphism contributes to the genetic susceptibility of epithelial ovarian cancer.
    Chen J; Kang S; Wu J; Zhao J; Si W; Sun H; Li Y
    J Obstet Gynaecol Res; 2022 May; 48(5):1240-1247. PubMed ID: 35150042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
    Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
    Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in
    Si W; Kang S; Sun H; Chen J; Cao S; Li Y
    Int J Gynecol Cancer; 2019 Sep; 29(7):1148-1155. PubMed ID: 31273068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV F protein amplifies the predictions of IL-28B and CTLA-4 polymorphisms about the susceptibility and outcomes of HCV infection in Southeast China.
    Xiao W; Zhang Q; Deng XZ; Jiang LF; Zhu DY; Pei JP; Ge CY; Li BJ; Wang CJ; Zhang JH; Zhou ZX; Ding WL; Xu XD; Yue M
    Infect Genet Evol; 2015 Aug; 34():52-60. PubMed ID: 26079279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of CTLA-4 gene polymorphisms with the genetic susceptibility and prognosis of patients with Bladder urothelial carcinoma].
    Li J; Zhang L; Xie H; Ge Y; Wang L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Aug; 41(8):988-993. PubMed ID: 39097285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
    Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
    DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
    Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
    Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
    Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
    J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms and Circulating Plasma Protein Levels of Immune Checkpoints (CTLA-4 and PD-1) Are Associated With Posner-Schlossman Syndrome in Southern Chinese.
    Huang X; Liu X; Ye Y; Zhang T; Mei S; Zhu T; Peng S; Cai J; Yan Z; Zeng K; Nie D; Sun L; Hou X; Zhao J
    Front Immunol; 2021; 12():607966. PubMed ID: 33717091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of CD152 polymorphisms on cervical cancer susceptibility.
    Cao S; Zheng L
    Pathol Res Pract; 2020 Aug; 216(8):152918. PubMed ID: 32616425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CTLA-4, TNF alpha and IL 10 polymorphisms with susceptibility to hepatocellular carcinoma.
    Wang JJ; Wang ZB; Tan TC
    Scand J Immunol; 2019 Dec; 90(6):e12819. PubMed ID: 31448426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis.
    Pang H; Luo S; Huang G; Li X; Xie Z; Zhou Z
    Biochem Genet; 2022 Aug; 60(4):1222-1235. PubMed ID: 34822071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.
    Fang M; Huang W; Mo D; Zhao W; Huang R
    Cell Physiol Biochem; 2018; 47(1):414-427. PubMed ID: 29794444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Thyroid Cancer and CTLA-4 Gene Polymorphisms.
    Sun L; Niu T; Zhang Y
    Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):31-36. PubMed ID: 37329551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T-lymphocyte Antigen-4 (
    VAN Nguyen S; Shamoun L; Landerholm K; Andersson RE; Wagsater D; Dimberg J
    In Vivo; 2021; 35(2):969-975. PubMed ID: 33622891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer.
    Xiong YH; He L; Fei J
    Int Immunopharmacol; 2014 Jan; 18(1):71-6. PubMed ID: 24201079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
    Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
    Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
    Liang J; Li Y; Wang N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of Association Between CTLA-4 Genetic Polymorphisms and Noncardiac Gastric Cancer in a Chinese Population.
    Liu J; Tang W; Lin W; Wang Y; Chen Y; Wang J; Liu M; Xu W; Lin J; Zhang L
    DNA Cell Biol; 2019 May; 38(5):443-448. PubMed ID: 30888206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.